Sanofi forecasts stronger profit growth, announces €5 billion stock buyback
Sanofi (NASDAQ:SNY) announced on Thursday that it plans to repurchase €5 billion ($5.21 billion) worth of shares this year and may take a more active approach to acquisitions in the near term. The ...
Nasdaq23d
Sanofi Down 10% in 3 Months: How Should You Play the Stock?
Sanofi’s SNY stock has declined 10.2% in the past three months. However, a lot of this price decline was due to the downtrend of the overall drug and biotech sector, which performed poorly in ...
Nasdaq9d
Sanofi's Opella: FDA Lifts Clinical Hold On OTC Cialis Trial
(RTTNews) - Sanofi's Consumer Healthcare division ... and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New ...
Nasdaq8d
Sanofi Announces Expanded Marketing Authorization For Sarclisa In The EU - Quick Facts
(RTTNews) - Sanofi (SNYNF, SNY ... the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New York, with ...
Sanofi upgraded to hold by Deutsche Bank
Deutsche Bank has upgraded Sanofi (NASDAQ:SNY) to hold from sell, citing the company's Q4 earnings report. The investment ...
Nasdaq8d
Lobbying Update: $690,000 of SANOFI US SERVICES INC lobbying was just disclosed
$690,000 of SANOFI US SERVICES INC lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing. This included lobbying on issues like: "Issues related to Pharmacy Benefit ...
Nasdaq7d
SNY's Sarclisa Gets EU Nod for Expanded Use in Multiple Myeloma
Sanofi SNY announced that the European Commission (“EC”) has granted marketing authorization to expand the use of its multiple myeloma (MM) drug, Sarclisa (isatuximab). With this nod, Sarclisa ...
Nasdaq17d
Sanofi's Sarclisa Gets First Approval In China For Relapsed Or Refractory Multiple Myeloma In Adults
(RTTNews) - French drug major Sanofi (SNY) announced Monday that its ... of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in ...
Sanofi (NASDAQ:SNY) Shares Sold by Geneos Wealth Management Inc.
Geneos Wealth Management Inc. decreased its position in Sanofi (NASDAQ:SNY – Free Report) by 2.1% in the 4th quarter, Holdings Channel.com reports. The fund owned 10,223 shares of the company’s stock ...
Time To Be Bullish On Sanofi Ahead Of Its Earnings
Dupixent continues leading among Sanofi’s portfolio, and it’s poised for up to $20 billion in peak sales. Read my SNY ...
Fifth Third Bancorp Has $1.23 Million Stock Holdings in Sanofi (NASDAQ:SNY)
Fifth Third Bancorp reduced its stake in Sanofi (NASDAQ:SNY – Free Report) by 9.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange ...
Sanofi (NASDAQ:SNY) Shares Purchased by Clarius Group LLC
Clarius Group LLC lifted its holdings in shares of Sanofi (NASDAQ:SNY – Free Report) by 11.9% in the fourth quarter, ...